Valuation: Biogen Inc.

Market Cap 3.08TCr 2.7TCr 2.48TCr 2.3TCr 4.38TCr 2,93600Cr 4.44TCr 30TCr 12TCr 1,44100Cr 12TCr 11TCr 4,99600Cr P/E 2026 *
31.8x
P/E 2027 * 17.5x
Enterprise Value 3.62TCr 3.17TCr 2.92TCr 2.71TCr 5.15TCr 3,45400Cr 5.22TCr 35TCr 14TCr 1,69500Cr 14TCr 13TCr 5,87800Cr EV / Sales 2026 *
3.6x
EV / Sales 2027 * 3.28x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.99%
1 week-2.63%
Current month-2.63%
1 month+9.22%
3 months+19.80%
6 months+12.56%
Current year+19.54%
1 week 208.27
Extreme 208.27
219.02
1 month 192.18
Extreme 192.18
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
282.74
5 years 110.04
Extreme 110.035
372.12
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Director

1,505 0.0010%
09/06Free

Director

1,505 0.0010%
09/06Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+0.99%-2.63%+61.67%-23.52% 3.08TCr
+1.73%+6.33%+23.21%-4.25% 6.61TCr
+0.24%-2.67%+50.09%+225.50% 5.53TCr
-1.13%+40.50%+40.50%+40.50% 4.24TCr
-0.21%+8.04%-50.01%-53.55% 4.13TCr
-1.60%+17.34%+174.83%-30.87% 3.25TCr
+1.33%+2.95%+73.48%+88.01% 2.31TCr
-3.65%+9.55%+5.63%+188.26% 2.01TCr
-0.23%+3.81%+67.69%+135.79% 1.72TCr
-1.52%+2.52%+75.53%+352.07% 1.52TCr
Average -0.42%+5.51%+52.26%+91.80% 3.44TCr
Weighted average by Cap. -0.07%+4.22%+45.52%+68.25%

Financials

2026 *2027 *
Net sales 1.01TCr 880.63Cr 811.11Cr 752.89Cr 1.43TCr 96TCr 1.45TCr 9.71TCr 3.78TCr 47TCr 3.78TCr 3.69TCr 1,63200Cr 1.04TCr 909.37Cr 837.58Cr 777.46Cr 1.48TCr 99TCr 1.5TCr 10TCr 3.9TCr 49TCr 3.9TCr 3.81TCr 1,68600Cr
Net income 152.22Cr 133.31Cr 122.79Cr 113.98Cr 216.44Cr 15TCr 219.37Cr 1.47TCr 572.03Cr 7.13TCr 571.65Cr 559.11Cr 25TCr 196.89Cr 172.43Cr 158.82Cr 147.42Cr 279.95Cr 19TCr 283.74Cr 1.9TCr 739.89Cr 9.22TCr 739.39Cr 723.17Cr 32TCr
Net Debt 542.95Cr 475.52Cr 437.98Cr 406.54Cr 772Cr 52TCr 782.45Cr 5.24TCr 2.04TCr 25TCr 2.04TCr 1.99TCr 88TCr 331Cr 289.89Cr 267.01Cr 247.84Cr 470.64Cr 32TCr 477.01Cr 3.2TCr 1.24TCr 15TCr 1.24TCr 1.22TCr 54TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
07/26/07 $210.07 +0.77% 22,634
06/26/06 $208.46 -3.54% 12,18,492
02/26/02 $216.12 +3.04% 11,55,165
01/26/01 $209.74 -2.93% 11,38,639
30/26/30 $216.06 -0.26% 10,91,325
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
208.46USD
Average target price
221.96USD
Spread / Average Target
+6.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock